Prospective data linkage to facilitate COVID-19 trials – A call to action

International Journal of Population Data Science

Matthew Sydes, Professor¹  Rhoswyn Walker, Dr.²  Michael J Schull, Professor³  Kimberlyn McGrail, Professor⁴  P Alison Paprica, Professor⁵  Andrew Morris, Professor⁶ 

[1] Health Data Research Network Canada;Health Data Research UK;Institute of Clinical Trials and Methodology, UCL;University of Toronto;ICES, 2075 Bayview Ave, Toronto, ON, M4N 3M5, Canada;Medical Research Council Clinical Trials Unit at University College London (UCL), 90 High Holborn, London, WC1V 6LJ, UK;

关键词: data linkage;    covid-19;    clinical trials;    administrative data;    electronic medical records;    registry data;   

DOI  :  10.23889/ijpds.v5i2.1383

来源: DOAJ

【 摘 要 】

Many countries around the world are creating COVID-19 trial datasets and databases of COVID-19-related data such as test results that cover entire populations. It is our strong recommendation, and sincere hope, that these data assets will be brought together through record linkage so that their scientific value and impact for society can be amplified. We call on trialists, data stewards and research funders to work together so that prospective linkage of trial data to medical databases becomes the norm, starting with COVID-19 trials.

【 授权许可】

Unknown